Evidence map›Paper›PMID 42390697›Full record

ArticleClinical rheumatology2026

A kaleidoscopic autoimmune syndrome (COVAS) following COVID-19 exposure.

Yuhui Li, Chuanhui Xu, Zhanguo Li

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuhui Li *Department of Rheumatology and Immunology, Peking University People's Hospital & Beijing Key Laboratory for Noninvasive Diagnosis and Immune Therapy (BZ0135), Beijing, China.ORCID http://orcid.org/0000-0002-5794-8172
Chuanhui Xu *Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.ORCID http://orcid.org/0000-0002-3222-7168
Zhanguo LiDepartment of Rheumatology and Immunology, Peking University People's Hospital & Beijing Key Laboratory for Noninvasive Diagnosis and Immune Therapy (BZ0135), Beijing, China. li99@bjmu.edu.cn.ORCID http://orcid.org/0000-0002-2590-6242

Funding

Beijing Natural-Science Foundation L222017National Natural Science Foundation of China 82371804National Natural Science Foundation of China 92374202Peking University People's Hospital Scientific Research Development Foundation RDX2023-03Peking University People's Hospital Scientific Research Development Foundation RZ2024-02
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42390697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.